275 related articles for article (PubMed ID: 11472746)
1. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations.
Gaughan DJ; Kluijtmans LA; Barbaux S; McMaster D; Young IS; Yarnell JW; Evans A; Whitehead AS
Atherosclerosis; 2001 Aug; 157(2):451-6. PubMed ID: 11472746
[TBL] [Abstract][Full Text] [Related]
2. Influence of methionine synthase (A2756G) and methionine synthase reductase (A66G) polymorphisms on plasma homocysteine levels and relation to risk of coronary artery disease.
Laraqui A; Allami A; Carrié A; Coiffard AS; Benkouka F; Benjouad A; Bendriss A; Kadiri N; Bennouar N; Benomar A; Guedira A; Raisonnier A; Fellati S; Srairi JE; Benomar M
Acta Cardiol; 2006 Feb; 61(1):51-61. PubMed ID: 16485733
[TBL] [Abstract][Full Text] [Related]
3. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study.
Jacques PF; Bostom AG; Selhub J; Rich S; Ellison RC; Eckfeldt JH; Gravel RA; Rozen R;
Atherosclerosis; 2003 Jan; 166(1):49-55. PubMed ID: 12482550
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism C776G in the transcobalamin II gene and homocysteine, folate and vitamin B12 concentrations. Association with MTHFR C677T and A1298C and MTRR A66G polymorphisms in healthy children.
Aléssio AC; Höehr NF; Siqueira LH; Bydlowski SP; Annichino-Bizzacchi JM
Thromb Res; 2007; 119(5):571-7. PubMed ID: 16820193
[TBL] [Abstract][Full Text] [Related]
5. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women.
Barbosa PR; Stabler SP; Machado AL; Braga RC; Hirata RD; Hirata MH; Sampaio-Neto LF; Allen RH; Guerra-Shinohara EM
Eur J Clin Nutr; 2008 Aug; 62(8):1010-21. PubMed ID: 17522601
[TBL] [Abstract][Full Text] [Related]
6. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults.
Kluijtmans LA; Young IS; Boreham CA; Murray L; McMaster D; McNulty H; Strain JJ; McPartlin J; Scott JM; Whitehead AS
Blood; 2003 Apr; 101(7):2483-8. PubMed ID: 12642343
[TBL] [Abstract][Full Text] [Related]
7. Methionine synthase (MTR) 2756 (A --> G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome.
Bosco P; Guéant-Rodriguez RM; Anello G; Barone C; Namour F; Caraci F; Romano A; Romano C; Guéant JL
Am J Med Genet A; 2003 Sep; 121A(3):219-24. PubMed ID: 12923861
[TBL] [Abstract][Full Text] [Related]
8. Relationship between methionine synthase, methionine synthase reductase genetic polymorphisms and deep vein thrombosis among South Indians.
Naushad SM; Jain Jamal MN; Prasad CK; Rama Devi AR
Clin Chem Lab Med; 2008; 46(1):73-9. PubMed ID: 18034637
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms predisposing to hyperhomocysteinemia in cardiac transplant patients.
Miriuka SG; Langman LJ; Evrovski J; Miner SE; D'Mello N; Delgado DH; Wong BY; Ross HJ; Cole DE
Transpl Int; 2005 Jan; 18(1):29-35. PubMed ID: 15612980
[TBL] [Abstract][Full Text] [Related]
10. Methionine synthase reductase (MTRR) A66G polymorphism is not related to plasma homocysteine concentration and the risk for vascular disease.
Scazzone C; Acuto S; Guglielmini E; Campisi G; Bono A
Exp Mol Pathol; 2009 Apr; 86(2):131-3. PubMed ID: 19348062
[TBL] [Abstract][Full Text] [Related]
11. A common gene variant in methionine synthase reductase is not associated with peak homocysteine concentrations after nitrous oxide anesthesia.
Nagele P; Zeugswetter B; Eberle C; Hüpfl M; Mittlböck M; Födinger M
Pharmacogenet Genomics; 2009 May; 19(5):325-9. PubMed ID: 19339913
[TBL] [Abstract][Full Text] [Related]
12. A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease.
Brown CA; McKinney KQ; Kaufman JS; Gravel RA; Rozen R
J Cardiovasc Risk; 2000 Jun; 7(3):197-200. PubMed ID: 11006889
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage.
Botto N; Andreassi MG; Manfredi S; Masetti S; Cocci F; Colombo MG; Storti S; Rizza A; Biagini A
Eur J Hum Genet; 2003 Sep; 11(9):671-8. PubMed ID: 12939653
[TBL] [Abstract][Full Text] [Related]
14. Associations of MTRR A66G polymorphism and promoter methylation with ischemic stroke in patients with hyperhomocysteinemia.
Li D; Zhao Q; Zhang C; Huang X; Godfrey O; Zhang W
J Gene Med; 2020 May; 22(5):e3170. PubMed ID: 32034842
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in methionine synthase reductase and betaine-homocysteine S-methyltransferase genes: risk of placental abruption.
Ananth CV; Elsasser DA; Kinzler WL; Peltier MR; Getahun D; Leclerc D; Rozen RR;
Mol Genet Metab; 2007 May; 91(1):104-10. PubMed ID: 17376725
[TBL] [Abstract][Full Text] [Related]
16. The methionine synthase reductase 66A>G polymorphism is a maternal risk factor for spina bifida.
van der Linden IJ; den Heijer M; Afman LA; Gellekink H; Vermeulen SH; Kluijtmans LA; Blom HJ
J Mol Med (Berl); 2006 Dec; 84(12):1047-54. PubMed ID: 17024475
[TBL] [Abstract][Full Text] [Related]
17. Genetic evidence that nitric oxide modulates homocysteine: the NOS3 894TT genotype is a risk factor for hyperhomocystenemia.
Brown KS; Kluijtmans LA; Young IS; Woodside J; Yarnell JW; McMaster D; Murray L; Evans AE; Boreham CA; McNulty H; Strain JJ; Mitchell LE; Whitehead AS
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1014-20. PubMed ID: 12689917
[TBL] [Abstract][Full Text] [Related]
18. Joint associations of folate, homocysteine and MTHFR, MTR and MTRR gene polymorphisms with dyslipidemia in a Chinese hypertensive population: a cross-sectional study.
Li WX; Lv WW; Dai SX; Pan ML; Huang JF
Lipids Health Dis; 2015 Sep; 14():101. PubMed ID: 26337056
[TBL] [Abstract][Full Text] [Related]
19. No association between MTHFR A1298C and MTRR A66G polymorphisms, and MS in an Australian cohort.
Szvetko AL; Fowdar J; Nelson J; Colson N; Tajouri L; Csurhes PA; Pender MP; Griffiths LR
J Neurol Sci; 2007 Jan; 252(1):49-52. PubMed ID: 17113603
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects.
Zhu H; Wicker NJ; Shaw GM; Lammer EJ; Hendricks K; Suarez L; Canfield M; Finnell RH
Mol Genet Metab; 2003 Mar; 78(3):216-21. PubMed ID: 12649067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
